The attorneys at Sheller, P.C. are investigating the side effects associated with the drug Reglan®, including the serious and potentially irreversible tardive dyskinesia disorder.

If you or someone you know has experienced these or other side effects, contact us now to learn your rights and protect your health.

Tardive dyskinesia is a potentially permanent disorder caused by the neuroleptic drug Reglan® (generic name: metoclopramide).

Patients with tardive dyskinesia suffer prolonged, involuntary muscle movements which can cause contortions and sudden movements of the muscles of the face, mouth, jaw, tongue, eyes, neck, shoulders, torso, larynx, diaphragm, arms, legs, feet, and hands. Taking the drug longer than the 12-week treatment approved by the FDA may cause tardive dyskinesia or other neurological conditions including restless leg syndrome.

Tell us your story: Free Case Consultation Reviewing Cases Nationwide Submit your info to view recent Reglan® news links

On February 26, 2009, the FDA announced that manufacturers of metoclopramide must add a black box warning to their drug labels to warn about the risks associated with its use.

What is the Treatment for Tardive Dyskinesia?

There is no known standard treatment for tardive dyskinesia. People who develop the condition will require ongoing, complicated treatment and may become physically and vocationally disabled. 

The Connection Between Infant Tardive Dyskinesia and Reglan®:

FDA News: Warning on Metoclopramide
(Generic for Reglan®), 2009

Reglan® stories have recently appeared:

The Sheller, P.C. law firm has more than 30 years of extensive experience representing people individually and in class actions across the country in drug liability matters, including drugs that may cause tardive dyskinesia or similar symptoms. The firm is working with families nationwide, and is actively investigating Reglan® and the drugs Risperdal® and Seroquel®, among others.